# VERtebral Fracture Treatment Comparisons in Osteoporotic Women

> **NCT01709110** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 1366 (actual)

## Conditions studied

- Postmenopausal Osteoporosis

## Interventions

- **DRUG:** Teriparatide
- **DRUG:** Risedronate
- **DRUG:** Placebo
- **DRUG:** Calcium
- **DRUG:** Vitamin D

## Key facts

- **NCT ID:** NCT01709110
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 1366 (ACTUAL)
- **Last updated:** 2019-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01709110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01709110, "VERtebral Fracture Treatment Comparisons in Osteoporotic Women". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01709110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*